Article Sidebar

pdf
Date Published: 02/12/2025
Abstract Views: 0
Views pdf: 0
DOI: https://doi.org/10.51298/vmj.v556i1.16313
Issue
Vol. 556 No. 1 (2025)
Section
Các bài báo
How to Cite
Mai, N. Q. (2025). APPLYING MORISKY SCALE TO ASSESS ADHERENCE TO TREATMENT IN PARKINSON’S PATIENTS AT THE NEUROLOGY CLINIC OF AN GIANG CENTRAL GENERAL HOSPITAL. Vietnam Medical Journal, 556(1). https://doi.org/10.51298/vmj.v556i1.16313

APPLYING MORISKY SCALE TO ASSESS ADHERENCE TO TREATMENT IN PARKINSON'S PATIENTS AT THE NEUROLOGY CLINIC OF AN GIANG CENTRAL GENERAL HOSPITAL

Nhật Quang Mai

Main Article Content

Abstract

Background: Parkinson's is a chronic progressive disease of the central nervous system. People with Parkinson's often have many different diseases, so they have to take many types of medicine and many times a day. Therefore, we conducted a study to apply the Morisky scale to evaluate adherence to treatment in Parkinson's patients to improve the quality of life for Parkinson's patients. Patients and methods: Cross-sectional study design including 51 persons who admitted to An giang hospital from February 1st 2024 to Septemper 30 th 2024. Results: Among 51 stroke patients selected for the study sample, the average age of hospitalized patients was 64.8±12 years old, males accounted for 56.8% more than females. Adherence to treatment was 74.5%, non-adherence to treatment was 25.5% in parkinson's. Conclusion: Adherence to treatment was 74.5%, non-adherence to treatment was 25.5% in parkinson's.

Article Details

References

Doãn Thị Huyền. Tuân thủ điều trị thuốc của người bệnh parkinson điều trị ngoại trú tại bệnh viện Bạch Mai năm 2021 và một số yếu tố liên quan.
2. Aggarwal S, Paul G, Paul B S (2021). Factors Affecting Adherence to Pharmacotherapy in Parkinson's Disease. Ann Indian Acad Neurol, 24 (6), 879-884.
3. Castro G S, Aguilar-Alvarado C M, Zúñiga-Ramírez C (2021). Adherence to treatment in Parkinson's disease: A multicenter exploratory study with patients from six Latin American countries. Parkinsonism Relat Disord, 93, 1-7.
4. Gil G, Tosin MHS, Ferraz HB. The impact of the socioeconomic factor on Parkinson's disease medication adherence: a scoping review. Arq Neuropsiquiatr. 2024 Feb;82(2):1-8. doi: 10.1055/s-0044-1779608. Epub 2024 Feb 23. PMID: 38395420; PMCID: PMC10890916.
5. Kim S R, Kim J Y, Kim H Y (2021). Factors Associated with Medication Beliefs in Patients with Parkinson's Disease: A Cross-Sectional Study. J Mov Disord, 14 (2), 133-143.
6. Straka I, Minár M, Škorvánek M (2019). Adherence to Pharmacotherapy in Patients With Parkinson's Disease Taking Three and More Daily Doses of Medication. Front Neurol, 10, 799.
7. Yi Zhanmiao, Mao Yudan, He Chenxuan (2024). Medication adherence and costs of medical care among patients with Parkinson’s disease: an observational study using electronic medical records. BMC Public Health, 24 (1), 1202